(19)
(11)
EP 1 758 989 A2
(12)
(88)
Date of publication A3:
02.03.2006
(43)
Date of publication:
07.03.2007
Bulletin 2007/10
(21)
Application number:
05723204.3
(22)
Date of filing:
16.02.2005
(51)
International Patent Classification (IPC):
C12N
5/16
(2006.01)
A61K
35/12
(2006.01)
C12N
5/22
(2006.01)
(86)
International application number:
PCT/US2005/005052
(87)
International publication number:
WO 2005/123123
(
29.12.2005
Gazette 2005/52)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
(30)
Priority:
08.06.2004
US 864788
15.07.2004
US 588146 P
(71)
Applicant:
PrimeGen Biotech LLC
Irvine, CA 92618 (US)
(72)
Inventors:
SAYRE, Chauncey, B.
Irvine, CA 92606 (US)
SILVA, Francisco, J.
Rancho Cucamonga, CA 91730 (US)
(74)
Representative:
Green, Mark Charles
Urquhart-Dykes & Lord LLP 30 Welbeck Street
London W1G 8ER
London W1G 8ER (GB)
(54)
THERAPEUTIC REPROGRAMMING, HYBRID STEM CELLS AND MATURATION